Processing Your Payment
Please do not leave this page until complete. This can take a few moments.
Research & Development
-
WPI professor researching natural COVID-19 therapy
May 5, 2021A team of researchers including Worcester Polytechnic Institute Biology Professor Pamela Weathers has found that extracts from a medicinal herb known as sweet wormwood can inhibit the COVID-19 virus and two of its recent variants.
May 5, 2021
Framingham and Czech partnership seeks new Alzheimer’s test
May 5, 2021The Framingham pharmaceutical firm Alzheon has partnered with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences to develop a diagnostic assay to measure substances believed to be neurotoxic drivers of Alzheimer’s
May 5, 2021
Olympus completes $45M Westborough R&D site
April 8, 2021Medical optics firm Olympus Corp. has announced the completion of its new, 150,000-square-foot facility in Westborough.
April 8, 2021
Veristat acquires British clinical firm in European expansion
February 25, 2021Southborough life sciences firm Veristat has acquired British contract research company SQN Clinical in a move the company says will allow it to expand its European capacities.
February 25, 2021
Framingham firm acquires California analytical company
January 21, 2021Life sciences analytical technology firm SCIEX has completed the acquisition of Silicon Valley-based Intabio.
January 21, 2021
Biostage cuts third quarter losses
January 21, 2021Holliston biotechnology company Biostage, Inc. announced last week it had cut its third quarter losses through reductions in research and development and administrative expenses.
January 21, 2021
Marlborough Alzheimer’s treatment firm announces new board
December 31, 2020Marlborough’s Cognoptix, a healthcare company developing a system for early detection of Alzheimer’s disease, has formed a new board of directors following a recent funding round.
December 31, 2020
Natick startup secures $19M in funding
December 17, 2020Natick healthcare startup Naveris announced the closure of its Series A financing round Tuesday, noting it has raised $19 million since the company was founded.
December 17, 2020
Phio Pharma ends Q3 with $16.9M on hand
November 12, 2020Marlborough drugmaker Phio Pharmaceuticals has ended the third quarter of the year with $16.9 million on hand as it ramps up its research and development of its cancer therapy technology.
November 12, 2020
Cystic Fibrosis Foundation infuses $14M into Framingham firm
October 22, 2020The Cystic Fibrosis Foundation in Maryland has invested an additional $14 million into Framingham firm Synspira Therapeutics, a biopharmaceutical company, as it pursues clinical studies.
October 22, 2020
UMass researcher earns $2M grant for diabetes research
October 14, 2020A UMass Medical School researcher has obtained a $2-million grant to study how fat cells differ in people with and without type 2 diabetes.
October 14, 2020-
Marlborough Alzheimer’s treatment firm secures $2.6M in funding
October 1, 2020Marlborough’s Cognoptix, a healthcare company developing a system for early detection of Alzheimer’s disease, announced it has closed on an oversubscribed $2.6 millon Series R financing round.
October 1, 2020 
WBJ Podcast: Galaxy Life Sciences’ plans for a Worcester biotech cluster
September 22, 2020Webster developer Galaxy Life Sciences believes the Massachusetts life sciences industry is so strong, the company will have a new tenant lined up for its new $50-million biomanufacturing facility in a matter of months.
September 22, 2020
WBJ Podcast: COVID’s fallout in nursing homes
August 31, 2020In August, UMass Medical School in Worcester was tasked with working to address the problem of nearly 4 out of 5 coronavirus-related deaths coming in nursing homes.
August 31, 2020
40 Under Forty 2020: Zu Shen
Updated: August 17, 2020In 2018, Zu Shen joined MBI as vice president, counseling startup companies scientifically and advising them on commercializing their technologies.
Updated: August 17, 2020
Marlborough firm secures $2M weapons of mass destruction detection contract
August 13, 2020Marlborough company Block MEMS has received a $1.7 million contract from the U.S. Department of Homeland Security Countering Weapons of Mass Destruction for a system to detect trace quantities of drugs and chemicals in parcels in the United States.
August 13, 2020
WBJ Web partners
Most Recent
